- Home
- VSTA vs CDTX Comparison
VSTA vs CDTX Comparison
Compare VSTA & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTA
- CDTX
- Stock Information
- Founded
- VSTA 1966
- CDTX 2012
- Country
- VSTA Brazil
- CDTX United States
- Employees
- VSTA N/A
- CDTX N/A
- Industry
- VSTA Other Consumer Services
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VSTA Real Estate
- CDTX Health Care
- Exchange
- VSTA Nasdaq
- CDTX Nasdaq
- Market Cap
- VSTA 332.9M
- CDTX 333.3M
- IPO Year
- VSTA 2020
- CDTX 2015
- Fundamental
- Price
- VSTA $4.29
- CDTX $21.02
- Analyst Decision
- VSTA Sell
- CDTX Strong Buy
- Analyst Count
- VSTA 2
- CDTX 9
- Target Price
- VSTA $3.00
- CDTX $41.29
- AVG Volume (30 Days)
- VSTA 32.4K
- CDTX 202.2K
- Earning Date
- VSTA 08-06-2025
- CDTX 08-12-2025
- Dividend Yield
- VSTA N/A
- CDTX N/A
- EPS Growth
- VSTA N/A
- CDTX N/A
- EPS
- VSTA 1.00
- CDTX N/A
- Revenue
- VSTA $286,712,653.00
- CDTX $302,000.00
- Revenue This Year
- VSTA $14.62
- CDTX N/A
- Revenue Next Year
- VSTA $10.84
- CDTX N/A
- P/E Ratio
- VSTA $4.23
- CDTX N/A
- Revenue Growth
- VSTA 6.46
- CDTX N/A
- 52 Week Low
- VSTA $1.60
- CDTX $10.14
- 52 Week High
- VSTA $5.49
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- VSTA 53.38
- CDTX 39.72
- Support Level
- VSTA $4.18
- CDTX $21.14
- Resistance Level
- VSTA $4.50
- CDTX $22.60
- Average True Range (ATR)
- VSTA 0.17
- CDTX 1.54
- MACD
- VSTA 0.03
- CDTX -0.51
- Stochastic Oscillator
- VSTA 58.00
- CDTX 12.57
About VSTA Vasta Platform Limited
Vasta Platform Ltd operates as an education company in Brazil, engaged in providing end-to-end educational and digital solutions that cater to all needs of private schools operating in the K-12 educational segment. Its business segments are Content and EdTech Platform, and Digital Platform. The Content and EdTech platform derives its results from educational content solutions through digital and printed content, including textbooks, learning systems and other complementary educational services. The Digital Platform enables private schools to aggregate multiple learning strategies and helps them to focus on education through the Business' physical and digital e-commerce platform and other digital services.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.